LMP400

DRUG2 trials

Sponsors

National Cancer Institute (NCI)

Conditions

LymphomaNeoplasmNeoplasms

Phase 1

A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas

CompletedNCT01051635

National Cancer Institute (NCI)Lymphoma, Neoplasms

Start: 2010-01-25End: 2017-06-21Updated: 2025-07-17

Indenoisoquinoline LMP400 for Advanced Solid Tumors and Lymphomas

CompletedNCT01794104

National Cancer Institute (NCI)Lymphoma, Neoplasm

Start: 2013-02-15End: 2017-10-27Updated: 2018-09-27

Related Papers

Phase 1 studies of the indenoisoquinolines LMP776 and LMP744 in patients with solid tumors and lymphomas

Cancer Chemotherapy and Pharmacology2025-05-291 citations

Phase I study of indenoisoquinolines LMP776 in adults with relapsed solid tumors and lymphomas.

Journal of Clinical Oncology2017-05-2011 citations